Israeli biotech companies fulfilling their destiny
Categories: Hi-Tech
Last year was considered a golden age of IPOs for Israeli startups and tech companies. Biotech hadn’t typically been part of that trend. No more. From January to August 2021, there were 65 biotech companies listed in the U.S., while in all of 2020 there were just 71 such offerings.
In an article in Calcalist, Pearl Cohen‘s Dr. Tamar van der Boom, a Senior Patent Attorney, and Adv., and Patent Attorney Yoav Alkalay, Senior Partner, discuss where the biotech sector is headed.
Read the full article in Globes here.
